Oklo is trading 12.89% up at $47.67 after its Groves Isotope Test Reactor achieved first criticality in Texas on August 5, announced August 6.
- A controlled, self-sustaining chain reaction under the U.S. Department of Energyβs Reactor Pilot Program marked its first privately built reactor on greenfield land.
- The milestone provides major technical validation and is the clearest explanation for the sharp move.
- Strong August 7 intraday momentum followed a 4.20% premarket gain; markets were mixed or weaker.